Competition for patients: Participatory Medicine
Mar 2, 2009
by Liz Moench
In the 1990s we saw an evolution of “right to know” and “right to choose” and even participation in clinical trial design by AIDS and cancer patients. In the 2000s we saw patient rights expand to include: “right to understand”, “right to blame,” “right to quality of life” and more. I believe that it is important to continue to bring information to patients to assist them in their decision-making process. It is for this reason that 20 years ago we again pioneered to bring clinical trials information directly to patients for a cancer drug, and continue to inform patients about clinical trials opportunities across many diseases today.
Pharmaceuticals and Healthcare recently posted an article regarding the patient and how they are the basis of the pharamaceutical and healthcare industry.
